Retatrutide 40mg – Pen

Certainly.

Retatrutide 40mg Pen is a research-grade peptide formulation supplied in a sterile, pre-filled pen for laboratory and investigational use only. It contains Retatrutide, a triple receptor agonist that acts on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, which are key pathways involved in metabolic regulation, glucose homeostasis, and energy balance.

This compound is being studied in clinical research for its potential role in obesity and metabolic disorder models, where simultaneous activation of these three receptors has been associated with effects on appetite regulation, insulin secretion, and energy expenditure in experimental settings.

Each pen contains 40mg of Retatrutide in a ready-to-use liquid formulation designed for accurate and consistent dosing in controlled research environments. The peptide is not intended for direct human consumption outside of approved clinical trials and remains strictly for research purposes only.